Navigation Links
US Patent Office Rejects 95% of Verathon Claims in Patent Case With Aircraft Medical
Date:3/26/2009

EDINBURGH, Scotland, March 26 /PRNewswire/ -- On March 23, 2009 the United States Patent and Trademark Office ("USPTO") issued a Non-Final Action Closing Prosecution in the ongoing re-examination of Verathon, Inc.'s United States Patent Number 6,543,447. Aircraft Medical, Ltd. filed the request for the re-examination of this patent in 2006 following litigation (currently on hold) that Verathon initiated against Aircraft.

The new Action from the USPTO has rejected 393 claims that Verathon introduced during the re-examination procedure on grounds that they had impermissibly enlarged the scope of the patent. The remaining 19 claims that have been characterized as "patentable" have been substantially limited in scope compared to the original claims. This is not a final decision and Aircraft believes that the decision to uphold these limited remaining claims will be overturned on appeal.

Aircraft believes that this severe limiting of the claims represents a significant setback for Verathon and that the USPTO's characterization of even the remaining claims as "patentable" will be reversed in further proceedings. Aircraft maintains its position that none of its products fall within either the original or amended claims of Verathon's US Patent Number 6,543,447.

Background

Aircraft Medical is the manufacturer of the McGrath(R) Series 5, the world's first fully portable video laryngoscope. Its compactness, and a cable free design, means the life saving benefits of video laryngoscope technology can fit in the pocket of a paramedic or mobile user. As a result, it is immediately available for use in potentially life threatening cases. The McGrath(R) Series 5 is leading the growth of the portable video laryngoscope market with distribution in North America, Europe and Australasia. Matt McGrath, Aircraft Medical's CEO, was last year named "Young Scot of the Year" by the Institute of Contemporary Scotland in recognition of the invention of McGrath(R) Series 5 and its advancement of healthcare and subsequent international success.

    Contact:
    Financial Dynamics
    Jonathan Birt: +44(0)207-269-7205
    John Dineen: +44(0)207-269-7205



'/>"/>
SOURCE Aircraft Medical Limited
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Dynavax Issued Landmark Patent Covering Second-Generation TLR9 Agonists
2. VisEn Medical Files Action to Invalidate New Caliper Life Sciences Patent
3. Pressure BioSciences, Inc. Issued First Patent in Canada
4. Oncolytics Biotech Inc. Announces Issuance of 23rd U.S. Patent
5. CODA Genomics Announces Issuance of Optimized Synthetic Gene Production Patent
6. Forest Laboratories Announces Federal Appeals Court Upholds Lexapro(R) Patent Decision
7. Weil Gotshal Wins Major Victory for Applera; Secures Summary Judgment Invalidating Three Patents
8. Angiotech receives favourable patent decision from New Zealands Intellectual Property Office
9. Angiotech reaches agreement with Johnson & Johnson to settle outstanding patent litigation
10. Warner Chilcott Announces New Information in USPTO Reexamination of Taclonex Patent
11. Intellect Neurosciences, Inc. Obtains Validation of European Patent for Alzheimers Vaccine in 19 Countries
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2017)... ... May 25, 2017 , ... Throughout this webinar, participants will ... process development and economic goals were achieved in both industry and academic settings. ... system, along with techniques for scaling production of mesenchymal stem cells (MSCs) and ...
(Date:5/24/2017)... BOUNTIFUL, Utah (PRWEB) , ... May 24, 2017 ... ... announces the selection and implementation of CLEARAS Water Recovery’s Advanced Biological Nutrient Recovery ... a key component of a $24 million plant upgrade to sustainably meet current ...
(Date:5/24/2017)... May 23, 2017 As Ebola resurfaces in the ... deaths and 20 suspected cases now reported, a new analysis ... database, showed a correlation between the 2014 and 2017 outbreaks ... rose sharply in 2012-13, which preceded the 2014 outbreak. An ... Ebola gene Replikin counts in 2014-15, which again precedes the ...
(Date:5/23/2017)... ... May 23, 2017 , ... Genedata, a ... anniversary, marking the occasion with a strong presence at Bio-IT World Conference & ... further extends an invitation to all attendees to view posters on the ...
Breaking Biology Technology:
(Date:4/5/2017)... 2017  The Allen Institute for Cell Science today ... one-of-a-kind portal and dynamic digital window into the human ... first application of deep learning to create predictive models ... and a growing suite of powerful tools. The Allen ... future publicly available resources created and shared by the ...
(Date:4/3/2017)... April 3, 2017  Data captured by ... platform, detected a statistically significant association between ... to treatment and objective response of cancer ... to predict whether cancer patients will respond ... as well as to improve both pre-infusion potency ...
(Date:3/29/2017)... 2017  higi, the health IT company that operates ... America , today announced a Series B investment ... EveryMove. The new investment and acquisition accelerates higi,s strategy ... transform population health activities through the collection and workflow ... higi collects and secures data today on behalf of ...
Breaking Biology News(10 mins):